SavedAdd your journal

Journals / Retina-Vitreus / 2014 / Cilt: 22 - Sayı: 4

Pars plana vitrectomy in refractory nontractional diabetic retinopathy

Tedaviye dirençli traksiyonel olmayan diabetik maküla ödemi olgularında pars plana vitrektomi

İbrahim KOÇAK
Ali AYDIN
Hacı KOÇ
Faruk KAYA
Pages
289–292
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It can be used as an adjunctive treatment in case of resistance to macular laser photocoagulation and intravitreal anti-VEGF injection which are less invasive methods.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Aim: To evaluate efficacy and safety of pars plana vitrectomy (PPV) in non-tractional diabetic macular edema (DME).
📊
Key Findings & Data:Materials and Methods: Eighteen eyes of 18 patients which underwent PPV by virtue of resistance to combined intravit- real triamcionolon acetonide injection and macular laser photocoagulation were rewieved retrospectively.
💡
Conclusion & Impact:It can be used as an adjunctive treatment in case of resistance to macular laser photocoagulation and intravitreal anti-VEGF injection which are less invasive methods.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: Aim: To evaluate efficacy and safety of pars plana vitrectomy (PPV) in non-tractional diabetic macular edema (DME). Materials and Methods: Eighteen eyes of 18 patients which underwent PPV by virtue of resistance to combined intravit- real triamcionolon acetonide injection and macular laser photocoagulation were rewieved retrospectively. Results: Baseline mean best spectacle corrected visual acuity (BSCVA) improved from 0.83±0.29 logMar to 0.70±0.31 log- Mar at the last follow-up visit after surgery (p=0.0686). Baseline mean macular thickness measured by OCT reduced from 434±72 &#956; (312-554 &#956;) to 369±51 &#956; (277-468 &#956;) at the last follow-up visit postoperatively (p<0.0001). Conclusion: PPV is controversial in the treatment of diffuse DME. It can be used as an adjunctive treatment in case of resistance to macular laser photocoagulation and intravitreal anti-VEGF injection which are less invasive methods.

Özet

Amaç: Traksiyonel olmayan diyabetik maküla ödemi (DMÖ) olgularında pars plana vitrektomi (PPV) girişiminin etkinlik ve güvenirliğini araştırmak. Gereç ve Yöntem: Traksiyonel olmayan DMÖ tanısıyla kombine intravitreal triamsinolon asetonid injeksiyonu ve makü- lar laser fotokoagulasyon tedavisi uygulanan, ancak direnç nedeni ile PPV yapılan 18 olgu retrospektif olarak değerlen- dirildi. Bulgular: Ortalama en iyi düzeltilmiş görme keskinliği (EDGK) ameliyat öncesinde 0.83±0.29 logMar iken, bu değer ame- liyat sonrası son kontrol için 0.70±0.31 logMar olarak saptanmıştır (p=0.0686). Ameliyat öncesi optik koherens tomografi ile 434±72 μ (312-554 μ) ölçülen ortalama maküla kalınlığı, ameliyat sonrası kayıtlı en son muayenede 369±51 μ (277-468 μ) olarak bulunmuştur (p<0.0001). Sonuç: PPV’nin diffüz DMÖ tedavisindeki yeri tartışmalıdır. Diffüz DMÖ olgularında daha az invazif yöntemler olan laser fotokoagulasyon ve anti-VEGF injeksiyonu gibi yöntemlere yanıt alınamıyorsa ek bir tedavi seçeneği olarak PPV düşünü- lebilir.

🔖

Cite This Article

KOÇAK, İ., AYDIN, A., KOÇ, H., KAYA, F. (2014). Pars plana vitrectomy in refractory nontractional diabetic retinopathy. Retina-Vitreus, Cilt: 22 - Sayı: 4, 289–292. https://ajindex.com/articles/305024

References (15)

  1. J B Clark, R H Grey, K K Lim and C J Burns-Cox. Loss of vision before ophthalmic referral in blind and partially sighted diabetics in Bristol. Br J Ophthalmol 1994
  2. Klein R, Klein BE, Moss SE, et al. The wisconsin epidemiologic study of diabetic retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995
  3. Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse dia- betic macular edema: long-term visual results. Ophthalmology 1991
  4. Olk RJ. Modified grid argon (blue-green) laser photocoagulation for dif- fuse diabetic macular edema. Ophthalmology 1986
  5. McDonald HR, Schatz H. Grid photocoagulation for diffuse macular edema. Retina 1985
  6. Kaiser PK, Reimann CD, Sears JE, et al. Macular traction detachment and diabetic macular edema associated with posterior hyaloid traction. Am J Ophthalmol 2001
  7. Yamamoto T, Hitani K, Tsukara I, et al. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic mac- ular edema. Am J Ophthalmol 2003
  8. Lewis H, Abrams GH, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloid traction. Ophthalmology 1992
  9. Patel JI, Hykin PG, Schadt M, et al. Pars plana vitrectomy with and without peeling of the ınner limiting membrane for diabetic macular edema. Retina 2006
  10. La Heij EC, Hendrikse F, Kessels AG, et al. Vitrectomy results in dia- betic macular oedema without evident vitreomacular traction. Graefe’s Arch Clin Exp Ophthalmol 2001
  11. Dillinger P, Mester U. Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular oedema. Graefe’s Arch Clin Exp Ophthalmol 2004
  12. Early Treatment Diabetic Retinopathy Study research group. Photoco- agulation for diabetic macular edema. Early Treatment Diabetic Reti- nopathy Study report number 1. Arch Ophthalmol 1985
  13. Gillies MC, Sutter FK, Simpson JM, et al. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double- masked, placebo-controlled, randomized clinical trial. Ophthalmology 2006
  14. Shulman S, Ferencz JR, Gilady G, et al. Prognostic factors for visual acuity improvement after intravitreal triamcinolone injection. Eye 2007
  15. Nicolo M, Nasciuti F, Lai S, et al. Intravitreal triamcinolone aceton- ide as primary treatment for diffuse diabetic macular edema